On-Chip ESR Measurements of DPPH at mK Temperatures☆
-
Add time:08/21/2019 Source:sciencedirect.com
We study electron spin resonance (ESR) of DPPH at mK temperatures. Here we employ a superconducting coplanar microwave resonator that allows convenient implementation in a dilution refrigerator as well as operation at multiple ESR frequencies, in this case 1.5 GHz, 3.0 GHz, and 4.5 GHz. We find a strong temperature and magnetic field dependence of the ESR of DPPH below 1 K, which is consistent with an antiferromagnetic transition. Our study documents the potential of this on-chip ESR technique for mK experiments and elucidates the possibility to use DPPH as an ESR reference material in this regime.
We also recommend Trading Suppliers and Manufacturers of MK 287 (cas 135947-75-0). Pls Click Website Link as below: cas 135947-75-0 suppliers
Prev:Synthesis and biological activity of MK 287 (cas 135947-75-0) (L-680,573): a potent, specific and orally active paf receptor antagonist
Next:Research PaperCardiovascular effects of dexmedetomidine, with or without MK-467, following intravenous administration in cats) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Regional brain catecholamines and metabolites following THC, PCP and MK-80108/28/2019
- Effects of MK-801 and antidepressant drugs in the forced swimming test in rats08/27/2019
- ArticleThe NMDA receptor and cocaine: Evidence that MK-801 can induce behavioral sensitization effects08/26/2019
- Original articleBupivacaine-induced convulsion is suppressed by MK-80108/25/2019
- A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML)08/24/2019
- Research PapersStandardization and Identification of Minor Components of Silymarin (MK-001)08/23/2019
- Research PaperCardiovascular effects of dexmedetomidine, with or without MK-467, following intravenous administration in cats08/22/2019
- Synthesis and biological activity of MK 287 (cas 135947-75-0) (L-680,573): a potent, specific and orally active paf receptor antagonist08/20/2019
- Enantioselective synthesis of the PAF antagonist MK-28708/19/2019


